Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

EBITDA multiple

 

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.
March 10, 2022

Investors choose between Affidea and IVI RMA

Big private equity players in health care face a choice as to whether to go for Pan-European imaging group Affidea which is for sale through Goldman Sachs or for IVI RMA, the international fertility group.
March 3, 2022

Sanoptis plans expansion as sale rumours spread

Multiple sources have told HBI that fast-growing German and Swiss ophthalmology group Sanoptis might be looking at a Q2 sale, but HBI understands that is not entirely correct. HBI speaks to Sanoptis CEO Volker Wendel to set the record straight.
February 23, 2022

Fertility sector heating up with three major deals underway

The fertility sector is heating up with multiple deals underway. The UK’s largest group by revenue, CARE Fertility, has been bought for £300m by PE firm Nordic Capital; Reuters reports that of $2.2bn are currently being "lined up" for the largest international player, IVI-RMA. And Australia’s largest group, Virtus Health, is being bought by PE firm CapVest for an equity value of A$650m.
February 3, 2022

Voyage Care bought by Kuwaiti sovereign fund

Voyage Care, the UK’s largest provider of support for people with learning disabilities by revenue, has been acquired by Wren House Infrastructure, a London-based subsidiary of the Kuwait Investment Authority, Kuwait’s largest sovereign wealth fund. HBI explores the multiple paid, and the thinking behind it.
January 21, 2022

UK fertility provider set to sell

HBI can exclusively reveal that a substantial UK-based fertility provider looks set to come to market later this year. HBI speaks to sources about possible pricing and buyers.
January 20, 2022

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
December 22, 2021

PAI Partners and Ontario Teachers’ buy Veonet

HBI has been told that Paris based private equity firm PAI Partners and Ontario Teachers' Pension Plan Board have agreed to acquire Germany based ophthalmology network Veonet from Nordic Capital.
December 3, 2021

Dentistry: Rodericks Dental, KonfiDents sell

Two more dentistry platforms have been grabbed by two different private equity firms. NHS focused UK dental group Rodericks Dental has sold, HBI hears from multiple sources, and so has German-based KonfiDents. We name the buyers, the multiple, and consider why this development might shake up a stagnating market.
November 4, 2021

“Secret” Artemis sale talks, as Veonet process progresses

HBI understands that Montagu, owners of Artemis Augenkliniken which is Germany’s second-largest ophthalmology chain by revenue, is in bilateral talks to sell. HBI names the potential buyer, and also has a delve into the ongoing sale - and current finances - of Veonet Group.
October 21, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us